サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1136321

初代細胞の世界市場：動向と予測

Global primary cells market trends and forecasts
出版日: | 発行: BCC Research | ページ情報: 英文 108 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
初代細胞の世界市場：動向と予測
出版日: 2022年10月12日
発行: BCC Research
ページ情報: 英文 108 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の初代細胞の市場規模は、2022年に13億米ドルになるとみられています。

同市場は今後、2022年～2027年にかけて9.0%のCAGRで拡大し、2027年には19億米ドルに達すると予測されています。

当レポートでは、世界の初代細胞市場について調査し、市場の概要とともに、生物学的由来別、由来組織別、エンドユーザー別、用途別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 イントロダクション

第2章 まとめとハイライト

第3章 市場と技術の背景

  • 細胞
  • 細胞培養
  • 細胞株
  • 初代細胞
  • 初代細胞と細胞株
  • 初代細胞培養
  • 初代細胞の特性化
  • 初代細胞の培養

第4章 市場力学

  • 市場促進要因
  • 市場抑制要因
  • 市場動向

第5章 生物学的由来別市場内訳

  • イントロダクション
    • 動物初代細胞
    • ヒト初代細胞
  • 世界の初代細胞市場、生物学的由来別

第6章 由来組織別市場内訳

  • 初代造血/血液および免疫細胞
  • 初代皮膚細胞/皮膚細胞
  • 消化管細胞
  • 初代肝細胞/肝細胞
  • 初代肺/気道細胞
  • 腎・腎細胞
  • 初代心臓/心臓細胞
  • 筋骨格細胞
  • その他の初代細胞
  • 世界の初代細胞市場、由来組織別

第7章 エンドユーザー別市場内訳

  • 概要
  • 世界の初代細胞市場、エンドユーザー別
    • ライフサイエンス研究機関
  • 学術機関、その他の研究機関

第8章 用途別市場内訳

  • 概要
  • 基礎研究
  • 創薬
  • ADME、毒性学および安全性評価研究
  • 細胞治療研究

第9章 地域別市場内訳

  • 世界の初代細胞市場、地域別
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第10章 競合情勢

  • 概要

第11章 企業プロファイル

  • AMERICAN TYPE CULTURE COLLECTION
  • BIOIVT
  • CELL APPLICATIONS INC.
  • CELL BIOLOGICS
  • CHARLES RIVER LABORATORIES
  • DISCOVERY LIFE SCIENCES
  • LIFENET HEALTH
  • LONZA
  • MERCK KGAA
  • PELOBIOTECH GMBH
  • PROMOCELL GMBH
  • SCIENCELL RESEARCH LABORATORIES
  • THERMO FISHER SCIENTIFIC INC.
  • ZENBIO INC.
図表

List of Tables

  • Summary Table : Global Market for Primary Cells, by Biological Source Type, Through 2027
  • Table 1 : Advantages and Disadvantages of Primary Cells
  • Table 2 : Primary Cells vs. Cell Lines
  • Table 3 : Clinical Trials Initiated Between 2015 and 2021, by Condition
  • Table 4 : Biotech Funding (Capital Markets/IPOs/VCs), 2005-09 vs. 2020
  • Table 5 : Global Market for Primary Cells, by Biological Source Type, Through 2027
  • Table 6 : Relative Percentage of Each Immune Cell Type in Peripheral Blood Mononuclear Cells (PMBCs)
  • Table 7 : Primary Cells by Tissue Source Type
  • Table 8 : Global Market for Primary Cells, by Tissue Source Type, Through 2027
  • Table 9 : NIH Funding for Neuroscience Research, by Year
  • Table 10 : Global Market for Primary Cells, by End User Type, Through 2027
  • Table 11 : Drug Discovery and Development Workflow
  • Table 12 : Commonly Used Primary Cells for ADME, Toxicology, and Safety Assessment Studies
  • Table 13 : Applications of Primary Cells in Drug Discovery and Development
  • Table 14 : Stem Cell Uses in Research
  • Table 15 : U.S. NIH Funding for Various Stem Cell Research (SCR) Areas, 2014-2023
  • Table 16 : Global Market for Primary Cells, by Application Type, Through 2027
  • Table 17 : Total Financing for Regenerative Medicine, by Therapeutic Area
  • Table 18 : Global Market for Primary Cells, by Region, Through 2027
  • Table 19 : North American Market for Primary Cells, by Tissue Source Type, Through 2027
  • Table 20 : North American Primary Cells Market, by Country, Through 2027
  • Table 21 : NIH Funding for Selected Research Categories, by Year
  • Table 22 : European Market for Primary Cells, by Tissue Source Type, Through 2027
  • Table 23 : European Primary Cells Market, by Country, Through 2027
  • Table 24 : Number of Companies in the Life Sciences and Pharmaceutical Industry, with R&D Expenditure in Europe in 2019, by Country
  • Table 25 : Asia-Pacific Market for Primary Cells, by Tissue Source Type, Through 2027
  • Table 26 : Asia-Pacific Primary Cells Market, by Country, Through 2027
  • Table 27 : Gross Domestic Spending on R&D, by Country, Through 2019
  • Table 28 : RoW Market for Primary Cells, by Tissue Source Type, Through 2027
  • Table 29 : Competitive Analysis of Primary Cell Manufacturers/Suppliers, 2021

List of Figures

  • Summary Figure : Global Market for Primary Cells, by Biological Source Type, 2019-2027
  • Figure 1 : Basic Steps Used to Isolate Cells from Primary Tissue
  • Figure 2 : Drug Development Process
  • Figure 3 : Average R&D Intensities for Publicly Traded U.S. Companies, by Industry
  • Figure 4 : Global Pharmaceutical R&D Spending, 2010-2019
  • Figure 5 : Cellular Models Development Process
  • Figure 6 : Personalized Medicines Contribution in Total FDA Approvals
  • Figure 7 : Cell and Gene Therapy Pipeline, by Phase
  • Figure 8 : Facts About Animals in Research
  • Figure 9 : Global Market for Primary Cells, by Biological Source Type, 2019-2027
  • Figure 10 : Global Market Shares of Primary Cells, by Biological Source Type, 2021
  • Figure 11 : Blood Tissues and Isolated Cells
  • Figure 12 : Hematopoiesis/Blood Cell Development
  • Figure 13 : Functions of the Human Liver
  • Figure 14 : Applications of Primary Hepatocytes in Drug Discovery and Development
  • Figure 15 : Global Market for Primary Cells, by Tissue Source Type, 2019-2027
  • Figure 16 : Global Market Shares of Primary Cells, by Tissue Source Type, 2021
  • Figure 17 : Global Oncology Launches of Novel Active Substances, 2014-2021
  • Figure 18 : Clinical Trials Started from 2016 to 2021, by Condition
  • Figure 19 : Global Market for Primary Cells, by End User Type, 2019-2027
  • Figure 20 : Global Market Shares of Primary Cells, by End User Type, 2021
  • Figure 21 : Research Applications for Primary Cells
  • Figure 22 : Primary Cells vs. Immortalized Cell Lines in Drug Discovery Research
  • Figure 23 : Global Market for Primary Cells, by Application Type, 2019-2027
  • Figure 24 : Global Market Shares of Primary Cells, by Application Type, 2021
  • Figure 25 : Publications Referencing Cell Therapy, 2015-2021
  • Figure 26 : Global Market for Primary Cells, by Region, 2019-2027
  • Figure 27 : Global Market Shares of Primary Cells, by Region, 2021
  • Figure 28 : Business Expenditures on Pharmaceutical R&D and Government Budgets for Health-related R&D, 2018 (or nearest year)
  • Figure 29 : North American Market for Primary Cells, by Tissue Source Type, 2019-2027
  • Figure 30 : North American Market Shares of Primary Cells, by Tissue Source Type, 2021
  • Figure 31 : North American Primary Cells Market, by Country, 2019-2027
  • Figure 32 : CIHR Fiscal Year Investments, by Primary Theme, 2017-2020
  • Figure 33 : European Market for Primary Cells, by Tissue Source Type, 2019-2027
  • Figure 34 : European Market Shares of Primary Cells, by Tissue Source Type, 2021
  • Figure 35 : European Primary Cells Market, by Country, 2019-2027
  • Figure 36 : European Countries' Gross Domestic Spending on R&D, 2017-2019
  • Figure 37 : Asia-Pacific Market for Primary Cells, by Tissue Source Type, 2019-2027
  • Figure 38 : Asia-Pacific Market Shares of Primary Cells, by Tissue Source Type, 2021
  • Figure 39 : Asia-Pacific Primary Cells Market, by Country, 2019-2027
  • Figure 40 : RoW Market for Primary Cells, by Tissue Source Type, 2019-2027
  • Figure 41 : RoW Market Shares of Primary Cells, by Tissue Source Type, 2021
  • Figure 42 : Charles River Laboratories: Annual Revenue, 2019-2021
  • Figure 43 : Charles River Laboratories: Revenue Share, by Region/Country, 2021
  • Figure 44 : Charles River Laboratories' RMS Business Segment: Annual Revenue, 2019-2021
  • Figure 45 : Lonza: Annual Revenue, 2019-2021
  • Figure 46 : Lonza: Revenue Share, by Region, 2021
  • Figure 47 : Lonza's Cell & Gene Division: Annual Revenue, 2019-2021
  • Figure 48 : Merck KGaA's Life Science Segment: Annual Revenue, 2019-2021
  • Figure 49 : Merck KGaA's Life Science Segment: Revenue Share, by Business Unit, 2021
  • Figure 50 : Thermo Fisher Scientific: Annual Revenue, 2019-2021
  • Figure 51 : Thermo Fisher Scientific: Revenue Share, by Region, 2021
目次
Product Code: BIO236A

Highlights:

The global primary cells market should reach $1.9 billion by 2027 from $1.3 billion in 2022 at a compound annual growth rate (CAGR) of 9.0% for the forecast period of 2022 to 2027.

Human segment of the global primary cells market is expected to grow from $1.0 billion in 2022 to $1.6 billion in 2027 at a CAGR of 9.8% for the forecast period of 2022 to 2027.

Animal segment of the global primary cells market is expected to grow from $232.3 million in 2022 to $295.6 million in 2027 at a CAGR of 4.9% for the forecast period of 2022 to 2027.

Report Scope:

This report aims to provide a comprehensive study of the global market for primary cells, both in terms of quantitative and qualitative data, to help develop business/growth strategies, assess the market landscape, analyze their position in the current marketplace, and make informed business decisions regarding primary cells. Segmentation is based on biological source type, tissue source type, application, end user, and region.

Industry growth drivers, restraints, trends, and opportunities in the primary cells market are also discussed in detail. The report also provides information on the competitive landscape, elaborative company profiles, and the impact of COVID-19 on the market.

Report Includes:

  • 30 tables
  • A comprehensive overview of the global market for primary cells
  • Analyses of the global and regional market trends, with historic market revenue from 2019 to 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
  • Highlights of the upcoming market potential for primary cells, growth driving factors, and areas of focus to forecast this market into various segments and sub-segments
  • Estimation of the actual market size and revenue forecast for primary cells market in USD million terms, and corresponding market share analysis based on product type, product origin, application, end user, and region
  • Discussion of the industry value chain analysis providing a systematic study of key intermediaries involved, with emphasis on manufacturers, suppliers, and major types of end users
  • Identification of the companies that are best positioned to meet the demand for primary cells because of their proprietary technologies, strategic alliances, or other advantages
  • Analysis of the vendor landscape based on their recent developments, financials, and segmental revenues
  • Descriptive company profiles of the leading global players, including Charles River Laboratories, Lonza, Merck KGaA and Thermo Fisher Scientific

Table of Contents

Chapter 1 Introduction

  • 1.1 Study Goals and Objectives
  • 1.2 Reasons for Doing This Study
  • 1.3 Scope of Report
  • 1.4 Methodology Information Sources
  • 1.5 Geographic Breakdown
  • 1.6 Analyst's Credentials
  • 1.7 BCC Custom Research
  • 1.8 Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

  • 3.1 Cell
  • 3.2 Cell Culture
  • 3.3 Cell Lines
  • 3.4 Primary Cells
  • 3.5 Primary Cells vs. Cell Lines
  • 3.6 Primary Cell Culture
    • 3.6.1 Primary Cell Culture Media and Supplements
  • 3.7 Characterization of Primary Cells
  • 3.8 Primary Cell Culture Applications

Chapter 4 Market Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Increasing Incidence of Chronic Diseases
    • 4.1.2 Demand for Effective Drug Discovery and Development Process
    • 4.1.3 Minimizing Animal Testing
    • 4.1.4 Advances in Primary Cells Culture Technologies
    • 4.1.5 Growing Spending on Pharmaceutical R&D
    • 4.1.6 Strong Biotech Funding
    • 4.1.7 Growing Applications in 3D Cell Culture Models
    • 4.1.8 Growing Focus on Personalized Medicine
    • 4.1.9 Growing Demand in Cell Therapy Research
  • 4.2 Market Restraints
    • 4.2.1 Demanding Requirements of Primary Cells
    • 4.2.2 Donor Tissue Supply Issues
    • 4.2.3 Ethical and Regulatory Concerns
  • 4.3 Market Trends
    • 4.3.1 Growing Demand for HLA-Typed Human Primary Cells
    • 4.3.2 Impact of COVID- 19

Chapter 5 Market Breakdown by Biological Source Type

  • 5.1 Introduction
    • 5.1.1 Animal Primary Cells
    • 5.1.2 Human Primary Cells
  • 5.2 Global Market for Primary Cells by Biological Source

Chapter 6 Market Breakdown by Tissue Source Type

  • 6.1 Primary Hematopoietic/Blood and Immune Cells
    • 6.1.1 Overview
    • 6.1.2 Hematopoietic Stem Cells (HSCs)
    • 6.1.3 Applications
  • 6.2 Primary Dermatocytes/Skin Cells
    • 6.2.1 Overview
    • 6.2.2 Applications
  • 6.3 Gastrointestinal Cells
    • 6.3.1 Overview
    • 6.3.2 Applications
  • 6.4 Primary Liver Cells/Hepatocytes
    • 6.4.1 Overview
    • 6.4.2 Applications
  • 6.5 Primary Lung/Airway Cells
    • 6.5.1 Overview
    • 6.5.2 Applications
  • 6.6 Renal/Kidney Cells
    • 6.6.1 Overview
    • 6.6.2 Applications
  • 6.7 Primary Heart/Cardiac Cells
    • 6.7.1 Overview
    • 6.7.2 Applications
  • 6.8 Musculoskeletal Cells
    • 6.8.1 Overview
    • 6.8.2 Applications
  • 6.9 Other Primary Cells
    • 6.9.1 Primary Brain Cells
    • 6.9.2 Primary Brain Cells Applications
    • 6.9.3 Other Primary Cells
  • 6.10 Global Market for Primary Cells by Tissue Source Type
    • 6.10.1 Primary Hematopoietic/Blood and Immune Cells
    • 6.10.2 Primary Dermatocytes/Skin Cells
    • 6.10.3 Primary Gastrointestinal Cells
    • 6.10.4 Primary Liver Cells/Hepatocytes
    • 6.10.5 Primary Lung/Airway Cells
    • 6.10.6 Primary Renal/Kidney Cells
    • 6.10.7 Primary Heart/Cardiac Cells
    • 6.10.8 Primary Musculoskeletal Cells
    • 6.10.9 Other Primary Cells

Chapter 7 Market Breakdown by End User

  • 7.1 Overview
  • 7.2 Global Market for Primary Cells by End User Type
    • 7.2.1 Life Science Research Companies
  • 7.3 Academic and Other Research Institutes

Chapter 8 Market Breakdown by Application

  • 8.1 Overview
  • 8.2 Basic Research
  • 8.3 Drug Discovery
  • 8.4 ADME, Toxicology and Safety Assessment Studies
    • 8.4.1 ADME and Toxicology Studies
    • 8.4.2 Safety Assessment Studies
  • 8.5 Cell Therapy Research
    • 8.5.1 Basic Research
    • 8.5.2 Drug Discovery
    • 8.5.3 Cell Therapy Research

Chapter 9 Market Breakdown by Region

  • 9.1 Global Market for Primary Cells by Region
  • 9.2 North America
    • 9.2.1 Market Revenue, by Tissue Source Type
    • 9.2.2 Market Revenue, by Country
  • 9.3 Europe
    • 9.3.1 Market Revenue by Tissue Source Type
    • 9.3.2 Market Revenue, by Country
  • 9.4 Asia-Pacific
    • 9.4.1 Market Revenue by Tissue Source Type
  • 9.5 Rest of the World (RoW)
    • 9.5.1 RoW Primary Cells Market by Tissue Source Type

Chapter 10 Competitive Landscape

  • 10.1 Overview

Chapter 11 Company Profiles

  • AMERICAN TYPE CULTURE COLLECTION
  • BIOIVT
  • CELL APPLICATIONS INC.
  • CELL BIOLOGICS
  • CHARLES RIVER LABORATORIES
  • DISCOVERY LIFE SCIENCES
  • LIFENET HEALTH
  • LONZA
  • MERCK KGAA
  • PELOBIOTECH GMBH
  • PROMOCELL GMBH
  • SCIENCELL RESEARCH LABORATORIES
  • THERMO FISHER SCIENTIFIC INC.
  • ZENBIO INC.